Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml.
序列
人血浆载脂蛋白CIII蛋白产品,又称Apolipoprotein CIII, apolipoprotein, apolipoproteins.人血浆载脂蛋白CIII产品又称Apo CIII, ApoCIII, Apo C-III, Apo C3, ApoC3等.